Mendel Biotechnology, Inc.
Arriva Pharmaceuticals, Inc.
Venture Law Group
Fried, Frank, Harris Shriver & Jacobson LLP
Greg has spent more than 20 years advising biotech companies on corporate and complex transactional matters, including structuring and negotiating strategic R&D collaborations, interactions with academic institutions, board governance and venture and non-dilutive financings. His mix of business and legal in-house experience enables him to provide pragmatic, business-focused solutions to intricate challenges faced by life sciences companies. Representative clients include Aduro Biotech, Aimmune Therapeutics, The Bluefield Project for PFD, Pliant Therapeutics and Verana Health, Inc.
Mendel Biotechnology, Inc.
CEO
Venture Law Group and Heller Ehrman
Partner
Joe is or has been involved in a wide range of philanthropic and community organizations, including:
Joe has spoken on business law and ethics at the Massachusetts Institute of Technology (Program of Health Sciences and Technology), Ross School of Business at the University of Michigan (Net Impact Conference), and Boston College Law School.
Joe was a member of the National Finance Council and actively involved in the voter protection team for the Stacey Abrams for Governor campaign.